The new registration announced by the Australian Pesticides and Veterinary Medicines Authority on Thursday means the gel pain relief product is can be bought off the shelf from rural product resellers and used for all three husbandry practices.
Prior to the variation in the registration, livestock owners were only able to use Tri-Solfen was castration, unless it was prescribed by a vet for other purposes. Tri-Solfen has been registered for castration since 2016.
The product was originally developed for the sheep industry as a pain relief for mulesing. More than 80 per cent of Australia’s flock is understood to be treated with pain relief.
Tri-Solfen was developed by life science company Medical Ethics and is marketed by Bayer in Australia.
Medical Ethics managing director Allan Giffard said the variation in registration made the Tri-Solfen more accessible for the beef and dairy industries.
“The widespread adoption of pain relief has been remarkable,” Mr Giffard said.
“Based on the widespread uptake of Tri-Solfen, livestock producers have shown they are very willing to minimise pain and enhance wound healing that come with animal husbandry practices.”
Tri-Solfen is a pain relieving and wound healing formulation that has short term and long term analgesia, antiseptics, reduces blood loss and coats the wound. It costs between about a $1 and $1.50 to treat each animal. It is described as best suited to calves aged six to eight weeks and is designed to provide pain relief for 24 to 36 hours.